Cite
HARVARD Citation
Gawronska, A. et al. (2017). Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases. 23 (12), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gawronska, A. et al. (2017). Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases. 23 (12), p. . [Online].